Skip to main content

Iñigo Ojanguren Arranz

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Iñigo Ojanguren Arranz

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino, Letizia Traversi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 31/12/2024

Agudizaciones asmáticas de origen vírico y su impacto en diferentes fenotipos asmáticos: Etiología, mecanismos inmunológicos e inflamatorios.

IP: Iñigo Ojanguren Arranz
Collaborators: David Espejo Castellanos
Funding agency: Instituto de Salud Carlos III
Funding: 75020
Reference: PI21/01100
Duration: 01/01/2022 - 31/12/2024

AGUDIZACIONES ASMÁTICAS DE ORIGEN VÍRICO Y SU IMPACTO EN DIFERENTES FENOTIPOS ASMÁTICOS: ETIOLOGÍA, MECANISMOS INMUNOLÓGICOS E INFLAMATORIOS

IP: Iñigo Ojanguren Arranz
Collaborators: -
Funding agency: SOCIETAT CATALANA DE PNEUMOLOGIA
Funding: 12000
Reference: SOCAP/TEMA.LLIURE/2021/OJANGUREN
Duration: 20/03/2021 - 31/12/2023

ESTUDIO DE LOS MECANISMOS DE PROGRESIÓN A FIBROSIS PULMONAR EN PACIENTES CON NEUMONITIS POR HIPERSENSIBILIDAD

IP: Iñigo Ojanguren Arranz
Collaborators: -
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 157188.46
Reference: SLT008/18/00108
Duration: 03/08/2019 - 31/12/2021

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Meri Montero Cueto

Meri Montero Cueto

Administrative
Accounting and Revenue Unit
Finances Area
Read more
Amina Coucous

Amina Coucous

Research assistant
Infectious Diseases
Read more
Maria Azucena Melgarejo Sanabria

Maria Azucena Melgarejo Sanabria

Administration and Management
Infectious Diseases
Read more
Florina Elena Tudorache

Florina Elena Tudorache

Maintenance staff and general services
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.